CIK: 0001595851 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 14, 2022
Total Value: $356M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 500,000 | $39.66M | 11.1% | $79.32 | — | — | Put | 78464A870 |
| APLS | APELLIS PHARMACEUTICALS INC | 275,000 | $18.78M | 5.3% | $68.30 * | $51.44 | +15.0% | COM | 03753U106 |
| RLMD | RELMADA THERAPEUTICS INC | 500,000 | $18.51M | 5.2% | $37.02 * | $25.40 | +9.1% | Put | 75955J402 |
| — | REATA PHARMACEUTICALS INC | 725,000 | $18.22M | 5.1% | $25.13 | $25.13 | — | CL A | 75615P103 |
| RLMD | RELMADA THERAPEUTICS INC | 425,000 | $15.73M | 4.4% | $37.02 * | $25.40 | +9.1% | COM | 75955J402 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 550,000 | $15.48M | 4.3% | $28.15 * | $24.95 | 0.0% | COM | 03237H101 |
| — | DICE THERAPEUTICS INC | 700,000 | $14.2M | 4.0% | $20.28 | $15.53 | — | Call | 23345J104 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 500,000 | $14.07M | 4.0% | $28.15 * | $24.95 | 0.0% | Put | 03237H101 |
| AXSM | AXSOME THERAPEUTICS INC | 300,000 | $13.39M | 3.8% | $44.62 * | $36.01 | +38.7% | COM | 05464T104 |
| — | MIRATI THERAPEUTICS INC | 175,000 | $12.22M | 3.4% | $69.84 | $71.70 | — | COM | 60468T105 |
| SRPT | SAREPTA THERAPEUTICS INC | 110,000 | $12.16M | 3.4% | $110.54 * | $78.15 | +29.0% | COM | 803607100 |
| — | CTI BIOPHARMA CORP | 2,000,000 | $11.64M | 3.3% | $5.82 | $4.68 | — | COM | 12648L601 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 535,000 | $10.97M | 3.1% | $20.51 * | $17.40 | +3.3% | COM | 92790C104 |
| — | REVANCE THERAPEUTICS INC | 390,000 | $10.53M | 3.0% | $27.00 | $27.00 | — | COM | 761330109 |
| ASND | ASCENDIS PHARMA A/S | 95,000 | $9.81M | 2.8% | $103.26 | $125.70 | — | SPONSORED ADR | 04351P101 |
| COGT | COGENT BIOSCIENCES INC | 600,000 | $8.952M | 2.5% | $14.92 * | $10.34 | +32.5% | COM | 19240Q201 |
| PCVX | VAXCYTE INC | 360,000 | $8.64M | 2.4% | $24.00 * | $22.18 | +14.3% | COM | 92243G108 |
| — | IVERIC BIO INC | 463,700 | $8.319M | 2.3% | $17.94 | $7.65 | — | COM | 46583P102 |
| — | SEAGEN INC | 50,000 | $6.842M | 1.9% | $136.84 | $176.94 | — | Call | 81181C104 |
| — | KARUNA THERAPEUTICS INC | 30,000 | $6.748M | 1.9% | $224.93 | $126.78 | — | COM | 48576A100 |
| AXSM | AXSOME THERAPEUTICS INC | 150,000 | $6.693M | 1.9% | $44.62 * | $36.01 | +38.7% | Call | 05464T104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 525,000 | $6.615M | 1.9% | $12.60 * | $14.83 | -13.2% | COM | 09058V103 |
| ALT | ALTIMMUNE INC | 435,000 | $5.555M | 1.6% | $12.77 * | $14.76 | 0.0% | COM NEW | 02155H200 |
| — | TRICIDA INC | 500,000 | $5.24M | 1.5% | $10.48 | $10.48 | — | Call | 89610F101 |
| FOLD | AMICUS THERAPEUTICS INC | 500,000 | $5.22M | 1.5% | $10.44 * | $11.01 | +1.2% | COM | 03152W109 |
| — | REATA PHARMACEUTICALS INC | 200,000 | $5.026M | 1.4% | $25.13 | $25.13 | — | Call | 75615P103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 200,000 | $4.806M | 1.3% | $24.03 * | $18.21 | +23.2% | COM | 87164F105 |
| — | HORIZON THERAPEUTICS PUB L | 75,000 | $4.642M | 1.3% | $61.89 | $79.76 | — | SHS | G46188101 |
| — | KEZAR LIFE SCIENCES INC | 525,000 | $4.52M | 1.3% | $8.61 | $14.73 | — | COM | 49372L100 |
| — | ASTRIA THERAPEUTICS INC | 500,000 | $4.52M | 1.3% | $9.04 | $9.04 | — | COM | 04635X102 |
| — | BLUEPRINT MEDICINES CORP | 65,000 | $4.283M | 1.2% | $65.89 | $65.89 | — | COM | 09627Y109 |
| WHWK | AADI BIOSCIENCE INC | 200,000 | $2.826M | 0.8% | $14.13 * | $22.12 | -40.6% | COM | 00032Q104 |
| — | INTRA-CELLULAR THERAPIES INC | 60,000 | $2.792M | 0.8% | $46.53 | $46.53 | — | COM | 46116X101 |
| — | AEROVATE THERAPEUTICS INC | 150,000 | $2.487M | 0.7% | $16.58 | $16.58 | — | COM | 008064107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 300,000 | $2.328M | 0.7% | $7.76 * | $6.29 | +12.0% | CLASS A ORD | 61559X104 |
| — | RAPT THERAPEUTICS INC | 90,000 | $2.165M | 0.6% | $24.06 | $33.20 | — | COM | 75382E109 |
| — | TRICIDA INC | 200,000 | $2.096M | 0.6% | $10.48 | $10.48 | — | COM | 89610F101 |
| TARS | TARSUS PHARMACEUTICALS INC | 120,000 | $2.054M | 0.6% | $17.12 * | $31.23 | -49.2% | COM | 87650L103 |
| DSGN | DESIGN THERAPEUTICS INC | 100,000 | $1.672M | 0.5% | $16.72 * | $15.73 | +26.5% | COM | 25056L103 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 25,000 | $1.625M | 0.5% | $65.00 * | $69.48 | 0.0% | COM | 558868105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 65,000 | $1.593M | 0.4% | $24.51 * | $18.60 | 0.0% | COM | 76243J105 |
| — | IVERIC BIO INC | 61,300 | $1.1M | 0.3% | $17.94 | $7.65 | — | Call | 46583P102 |
| BIIB | BIOGEN INC | 3,750 | $1.001M | 0.3% | $266.93 * | $212.38 | 0.0% | COM | 09062X103 |
| — | AEGLEA BIOTHERAPEUTICS INC | 1,000,000 | $526K | 0.1% | $0.53 | $1.74 | — | COM | 00773J103 |